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Identity 




Episomal amplification of ABL detected by FISH with the commercial probe LSI BCR-ABL ES. 
 
Clinics and pathology 
Disease 
T-cell acute lymphoblastic leukemia (T-ALL). 
Phenotype / cell stem origin 
Immature T-cell leukemia (CD3+, CD2+ and CD7+). 
Not seen in B-cell ALL. 
Epidemiology 
In about 6% of T-ALL. Mainly observed in T-ALL 
associated with the mutually exclusive overexpression 
of the oncogenes HOX11 and HOX11L2. Found in 
pediatric T-ALL and adults T-ALL. 
Cytology 
Lymphoblasts. 
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Prognosis 
Present data suggests that NUP214-ABL1 fusion gene 
amplification in T-ALL is associated with poor 
outcome. NUP214-ABL1 is sensitive to the tyrosine 
kinase inhibitor imatinib mesylate. Targeting therapies 
may improve outcome. 
Cytogenetics 
Note: Mechanism of gene amplification. 
The main hypothesis for genomic amplification 
mechanism is that it is a dynamic process. Molecular 
chronology of genomic amplification has been 
schematically described as follows. The first step is the 
production of submicroscopic, acentric, circular, 
extrachromosomal DNA molecules which replicate 
autonomously, called episomes. These DNA molecules 
are made of amplified genes. 2 mechanisms for the 
formation of episomes have been proposed: 
Conservative which preserves the original DNA 
sequence at the native chromosomal locus and non 
conservative which leads to the deletion of the original 
sequence at the native locus. The second step 
corresponds to an increase in copy number resulting 
from unequal mitotic segregation and an increase in 
size. They enlarge over time to form progressively 
heterogeneously sized structures, microscopically 
visible, called double minutes (dmin). In a later step 
they may integrate into chromosomes to generate 
intrachromosomally amplified structures (HSR). In 
some cases dmins or HSRs may form directly without 
precursors. 
Cytogenetics morphological 
Cryptic extrachromosomal amplification of the fusion 
NUP214-ABL. Rearrangement invisible by 
conventional cytogenetics. No dmins observed. 
Cytogenetics molecular 
FISH using commercially available ABL1 probe shows 
multiple extrachromosomal sites on metaphases and 
multiple signals in interphase nuclei. The 
extrachromosomal amplification of ABL1 appears to be 
pathognomonique for the presence of NUP214-ABL1 
fusion in T-ALL. 
There may be a corresponding deletion of the ABL1 
probe on one of the chromosomes 9 (see note below 
concerning mechanisms of gene amplification). 
Additional anomalies 
Associated with an apparently normal karyotype with 
banding techniques or variable additional 
abnormalities. 
Genes involved and Proteins 
ABL1 
Location: 9q34.1 
DNA / RNA 
Alternate splicing. mRNA of 6 and 7 kb. 
Protein 
145 kDa; Localization: nuclear and cytoplasmic; 
Tyrosine kinase; Ubiquitously expressed. 
NUP214 (nuclear pore complex protein 
241 kDa) or CAN, CAIN, Nucleoporin 
Location: 9q34.3, more telomeric than ABL1. 
DNA / RNA 
7.5 kb mRNA. 
Protein 
214 kDa; dimerization domains (2 leucine zippers) and
a repeated motif; forms homodimers. Nuclear 
membrane localisation. Component of the Nuclear Pore 
Complex. Mediate nucleocytoplasmic transport. 




Molecular analysis delineated the amplicon as a 500 kb 
region from chromosome band 9q34 containing the 
genes ABL1, LAMC3 and NUP214. The genomic 
region from ABL1 to NUP214 circularizes to generate 
the NUP214-ABL1 fusion gene = New mechanism for 
generation of a fusion gene. The breakpoint within 
ABL1 occurs in intron1 (coincides with ABL1 
breakpoint in the Philadelphia chromosome). Whilst 
the breakpoint in NUP214 is variable (ranging from 





The NUP214-ABL transcript encodes a 239-333 kDa 
protein. NUP214-ABL retains the N-terminal region of 
NUP 214 which includes the predicted coiled-coil 
domains that serve as oligomerisation motifs. NUP214-
ABL contains SH3, SH2 and kinase domains of ABL1. 
NUP214-ABL is a constitutively activated tyrosine 
kinase that activates similar pathways as BCR-ABL1. 
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